Docusign (NASDAQ:DOCU) Stock Price Target Raised at BTIG Research

Docusign (NASDAQ:DOCU – Get Free Report) had its price objective upped by equities researchers at BTIG Research from $75.00 to $90.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. BTIG Research‘s price objective would suggest a potential upside of 18.53% from the stock’s previous close.

Several other brokerages have also recently weighed in on DOCU. UBS Group raised their price objective on Docusign from $54.00 to $70.00 and gave the company a “neutral” rating in a report on Friday, September 4th. Weiss Ratings upgraded Docusign from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Citizens Jmp reissued a “market outperform” rating and set a $86.00 price target on shares of Docusign in a research report on Friday, September 4th. Evercore set a $65.00 price target on Docusign in a research note on Friday, September 4th. Finally, Piper Sandler boosted their price target on Docusign from $52.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, September 4th. Three investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $68.56.

Read Our Latest Stock Analysis on Docusign

Docusign Price Performance

Docusign stock opened at $75.93 on Wednesday. Docusign has a 52-week low of $40.16 and a 52-week high of $85.90. The firm has a market capitalization of $14.19 billion, a P/E ratio of 46.30, a P/E/G ratio of 2.94 and a beta of 0.80. The stock has a fifty day moving average price of $74.45 and a two-hundred day moving average price of $56.02.

Docusign (NASDAQ:DOCU – Get Free Report) last posted its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.07. The company had revenue of $875.75 million for the quarter, compared to analyst estimates of $867.22 million. Docusign had a return on equity of 18.29% and a net margin of 9.82%. The business’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.30 earnings per share. On average, equities research analysts predict that Docusign will post 2.15 EPS for the current fiscal year.

Insider Buying and Selling at Docusign

In related news, CEO Allan C. Thygesen sold 26,250 shares of the business’s stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $69.29, for a total value of $1,818,862.50. Following the completion of the transaction, the chief executive officer owned 166,801 shares of the company’s stock, valued at $11,557,641.29. The trade was a 13.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Peter Solvik sold 46,000 shares of the business’s stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $65.24, for a total transaction of $3,001,040.00. Following the completion of the transaction, the director owned 49,558 shares of the company’s stock, valued at $3,233,163.92. The trade was a 48.14% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 154,168 shares of company stock valued at $10,491,896 in the last quarter. Company insiders own 0.59% of the company’s stock.

Institutional Investors Weigh In On Docusign

Several hedge funds and other institutional investors have recently made changes to their positions in DOCU. BlackRock Inc. acquired a new position in Docusign during the second quarter worth $927,059,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Docusign by 76.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock valued at $250,568,000 after buying an additional 2,283,996 shares in the last quarter. Bank of New York Mellon Corp acquired a new stake in shares of Docusign in the second quarter valued at $56,219,000. Man Group plc acquired a new stake in shares of Docusign in the second quarter valued at $52,714,000. Finally, Bank of America Corp DE purchased a new stake in shares of Docusign in the 2nd quarter valued at $46,178,000. 77.64% of the stock is owned by institutional investors.

About Docusign

(Get Free Report)

DocuSign, Inc. provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes. The company’s offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.

Featured Stories

Analyst Recommendations for Docusign (NASDAQ:DOCU)

Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.